Education
About Us
Working with TipRanks
Follow Us
Aquestive Therapeutics (AQST)
NASDAQ:AQST
Earnings Data
Report Date
Mar 10, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.14Last Year’s EPS
-0.19Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call emphasized strategic progress towards Anaphylm's FDA approval and significant financing achievements, fostering optimism about the product's launch and market potential. However, financial challenges such as increased net loss and decreased revenue highlight ongoing operational hurdles.Company Guidance
Anaphylm FDA Approval Progress
The FDA confirmed they are aiming for an on-time review with no Advisory Committee meeting required, positioning the company well for a potential Q1 2026 launch.
Successful Financing Rounds
Aquestive completed an $85 million equity raise and a $75 million commercial launch financing, providing capital support through 2027.
Increased Market Awareness and Engagement
Most allergists are aware of Anaphylm, with over 25% completing CME presentations, indicating strong prelaunch engagement.
International Expansion Plans
Positive interaction with Health Canada allows for filing in the first half of 2026, with ongoing discussions with the EMA for European approval.
AQST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AQST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $6.00 | $6.13 | +2.17% |
Aug 11, 2025 | $3.86 | $3.78 | -2.07% |
May 12, 2025 | $2.85 | $2.29 | -19.65% |
Mar 05, 2025 | $2.79 | $2.58 | -7.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Aquestive Therapeutics (AQST) report earnings?
Aquestive Therapeutics (AQST) is schdueled to report earning on Mar 10, 2026, After Close (Confirmed).
What is Aquestive Therapeutics (AQST) earnings time?
Aquestive Therapeutics (AQST) earnings time is at Mar 10, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AQST EPS forecast?
AQST EPS forecast for the fiscal quarter 2025 (Q4) is -0.14.